Clinical effects of arsenic trioxide by slowing-intravenous infusion on acute promyelocyte leukemia

Chinese Medical Sciences Journal

Volumn 20, Issue 2, 2005, Pages 137-

  Zhou, Jin ^a   Meng, Ran ^b   Yang, Bao Feng ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE;

BRAIN HEMORRHAGE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; NOTE; PHOTOMETER; PROMYELOCYTIC LEUKEMIA; RANDOMIZED CONTROLLED TRIAL;

ANTINEOPLASTIC AGENTS; ARSENICALS; CEREBRAL HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, PROMYELOCYTIC, ACUTE; LEUKOCYTOSIS; OXIDES;

EID: 23044452097     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (0)